Personal Profile

2025-Present  Postdoctoral Researcher, Institute of Metabolism and Integrative Biology, Fudan University

2021-2025  Ph.D. in Biochemistry and Molecular Biology, Institute of Metabolism and Integrative Biology, Fudan University

2018-2021  M.Sc. in Pharmacy, Shenyang Pharmaceutical University

2013-2018  B.Sc. in Pharmacy, Shenyang Pharmaceutical University

Research Interests

Tumor metabolism

Honors and Awards

2025 Fudan University Outstanding Graduate 

2024 National Scholarship for Graduate Students 

Selected Publications

1. Mi W#, Xia XY#, Xue Y#, Li LC, Yang L, Yang XC, Xu J, Cai XL, Zhou YJ, Zhu LZ, Wang GL, Li F, Ji HB, Tong XY*, Liu PY*, Li FM*. LKB1 inactivation elicits an NNMT-mediated methyl sink and confers dependence on PRMT5 in lung cancer. Cell Rep. 2026 Jun 23;45(6):117487.doi: 10.1016/j.celrep.2026.117487. Epub 2026 Jun 2

2. Mi W, You JW, Li LC, Zhu LZ, Xia XY, Yang L, Li F, Xu Y, Bi JF, Liu PY, Chen L, Li FM*. BET inhibition induces GDH1-dependent glutamine metabolic remodeling and vulnerability in liver cancer. Life Metabolism, 2024, loae016.

3. Li FM*#, Liu PY#, Mi W, Li LC, Anderson NM, Lesner NP, Burrows M, Plesset J, Majer A, Wang GL, Li JY, Zhu LZ, Keith B, Simon MC*. Blocking methionine catabolism induces senescence and confers vulnerability to GSK3 inhibition in liver cancer. Nat Cancer. 2024 Jan;5(1):131-146. (* co-corresponding).